These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12216070)
1. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070 [TBL] [Abstract][Full Text] [Related]
2. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Ferguson AW; Svoboda-Newman SM; Frank TS Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417 [TBL] [Abstract][Full Text] [Related]
3. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix]. Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348 [TBL] [Abstract][Full Text] [Related]
4. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923 [TBL] [Abstract][Full Text] [Related]
5. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions. Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma. Ocádiz R; Sauceda R; Salcedo M; Ortega V; Rodríguez H; Gordillo C; Chávez P; Gariglio P Arch Invest Med (Mex); 1989; 20(4):355-62. PubMed ID: 2562235 [TBL] [Abstract][Full Text] [Related]
8. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026 [TBL] [Abstract][Full Text] [Related]
9. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients. Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions. Choo KB; Chen CM; Han CP; Cheng WT; Au LC J Med Virol; 1996 May; 49(1):15-22. PubMed ID: 8732866 [TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
12. Physical status and expression of HPV genes in cervical cancers. Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401 [TBL] [Abstract][Full Text] [Related]
13. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512 [TBL] [Abstract][Full Text] [Related]
14. Correspondence re: Ferguson AM, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1:11-18, 1998. Tenti P; Zappatore R; Carnevali L Mod Pathol; 1999 Dec; 12(12):1192-3. PubMed ID: 10619275 [No Abstract] [Full Text] [Related]
15. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588 [TBL] [Abstract][Full Text] [Related]
16. Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction. Chang DY; Hsieh CY; Chen RJ; Lee SC; Huang SC J Med Microbiol; 1995 Dec; 43(6):430-5. PubMed ID: 7473676 [TBL] [Abstract][Full Text] [Related]
17. The c-myc activation in cervical carcinomas and HPV 16 infections. Abba MC; Laguens RM; Dulout FN; Golijow CD Mutat Res; 2004 Feb; 557(2):151-8. PubMed ID: 14729369 [TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763 [TBL] [Abstract][Full Text] [Related]
19. [The possibility of viral etiology in cervical carcinogenesis]. Iwasaka T Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417 [TBL] [Abstract][Full Text] [Related]
20. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA]. Nagai N Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]